A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux
Journal of Thrombosis and Thrombolysis, ISSN: 0929-5305, Vol: 33, Issue: 1, Page: 133-135
2012
- 4Citations
- 13Usage
- 30Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations4
- Citation Indexes4
- CrossRef2
- Usage13
- Abstract Views13
- Captures30
- Readers30
- 30
Article Description
Heparin-induced thrombocytopenia (HIT) is a rare immune-mediated complication associated with unfractionated heparin and to a lesser extent with low-molecular weight heparins. The American College of Chest Physicians recommends treating patients with suspected HIT with a non-heparin product regardless if thrombosis is present. The direct thrombin inhibitors are the preferred agents for the treatment of acute HIT (lepirudin, argatroban [Grade 1C]). Fondaparinux is also suggested as an alternative with a lower level of evidence (Grade 2C). The evidence supporting the use of fondaparinux in the treatment of HIT is limited, but the evidence of fondaparinux causing HIT is even less. We present a case of a patient who developed complications with fondaparinux when used in the acute setting of HIT. © Springer Science+Business Media, LLC 2011.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84858860028&origin=inward; http://dx.doi.org/10.1007/s11239-011-0641-2; http://www.ncbi.nlm.nih.gov/pubmed/21947717; http://link.springer.com/10.1007/s11239-011-0641-2; https://escholarship.umassmed.edu/meyers_pp/517; https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1816&context=meyers_pp; https://dx.doi.org/10.1007/s11239-011-0641-2; https://link.springer.com/article/10.1007/s11239-011-0641-2; http://www.springerlink.com/index/10.1007/s11239-011-0641-2; http://www.springerlink.com/index/pdf/10.1007/s11239-011-0641-2
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know